Pharvaris N.V. (PHVS)
NASDAQ: PHVS · IEX Real-Time Price · USD
16.85
-1.84 (-9.84%)
Jul 2, 2024, 4:30 PM EDT - Market closed
Pharvaris Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
82
Market Cap
906.81M USD
Revenue Chart
* The company reports in EUR currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 0 | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Owens & Minor | 10.42B |
MiMedx Group | 334.51M |
Innoviva | 311.59M |
Maravai LifeSciences Holdings | 274.10M |
Gyre Therapeutics | 140.62M |
BioLife Solutions | 137.30M |
Simulations Plus | 64.67M |
Tarsus Pharmaceuticals | 42.56M |
PHVS News
- 21 days ago - Pharvaris Announces Annual Meeting of Shareholders - GlobeNewsWire
- 4 weeks ago - Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses - GlobeNewsWire
- 7 weeks ago - Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses - GlobeNewsWire
- 7 weeks ago - Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer - GlobeNewsWire
- 3 months ago - Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference - GlobeNewsWire
- 3 months ago - Pharvaris Announces Phase 3 Clinical Study Design for Recently Initiated RAPIDe-3 Study, and Presents Quality-of-Life Improvement and Caregiver Behavior Data at Two Recent HAE Congresses - GlobeNewsWire